Gene therapy biotech Kriya Therapeutics is continuing its acquisition streak to build out a pipeline, this time with a focus on the brain. The North Carolina-based biotech is buying Redpin ...
Kriya Therapeutics has reeled in a whopping $270 million from its series C round, surpassing the $180 million raised in total over the last two years and solidifying ample financing to build out its ...
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics, Inc., a fully integrated gene therapy company pioneering novel technologies and therapeutics, today announced ...
RESEARCH TRIANGLE PARK, N.C. and PALO ALTO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc. ("Kriya"), a biopharmaceutical company developing gene therapies to address chronic ...
Kriya Payments is now available in 42 countries. This means buyers worldwide can “take advantage of flexible payment terms, feeling more secure about their cash flow.” General Manager, Martina ...
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., July 26, 2023 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc., a biopharmaceutical company developing gene therapies for conditions affecting millions ...
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy, ...
Please provide your email address to receive an email when new articles are posted on . Kriya Therapeutics Inc. announced the acquisition of biotech company Redpin Therapeutics Inc., bolstering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback